XWELL (NASDAQ:XWEL) Releases Quarterly Earnings Results, Beats Estimates By $0.74 EPS

XWELL (NASDAQ:XWEL) posted its quarterly earnings data on Friday. The company reported ($0.26) earnings per share for the quarter, topping the consensus estimate of ($1.00) by $0.74, Zacks reports. XWELL had a negative return on equity of 2,318.99% and a negative net margin of 81.43%.The firm had revenue of $7.14 million for the quarter, compared to analysts’ expectations of $2.37 million.

XWELL Stock Down 3.0%

NASDAQ:XWEL opened at $0.98 on Friday. XWELL has a 52-week low of $0.26 and a 52-week high of $2.20. The stock has a fifty day simple moving average of $1.07 and a 200-day simple moving average of $1.08. The company has a market capitalization of $8.27 million, a PE ratio of -0.18 and a beta of 1.03.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on XWEL. Weiss Ratings reissued a “sell (e+)” rating on shares of XWELL in a research report on Friday, August 7th. Wall Street Zen lowered XWELL from a “hold” rating to a “sell” rating in a research report on Sunday, May 17th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company presently has an average rating of “Sell”.

About XWELL

XWELL, Inc provides health and wellness services in airport and off airport marketplaces in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler's spa services, including massage, nail, and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels.